New management appointments at Xanodyne
This article was originally published in Scrip
Executive Summary
Xanodyne Pharmaceuticals (US), a speciality company focused on women's healthcare and pain management, has appointed three new members to its executive management team: Natasha Giordano as chief commercial officer; Rita O'Connor as chief financial and information officer; and Peter Wentworth as senior vice-president of human resources. Ms Giordano was most recently president, Americas, at Cegedim Dendrite, while Ms O'Connor was vice-president of finance at NPS Pharmaceuticals and Mr Wentworth was executive vice-president of human resources at Adams Respiratory Therapeutics.